Home  »  Business   »  Lifecore Biomedical Inc. (NASDAQ: LFCR) Stock Fore...

Lifecore Biomedical Inc. (NASDAQ: LFCR) Stock Forecast: Could Pass $8.00 In A Year

The trading price of Lifecore Biomedical Inc. (NASDAQ:LFCR) closed higher on Tuesday, May 23, closing at $8.05, 50.19% higher than its previous close.

Traders who pay close attention to intraday price movement should know that it fluctuated between $5.9106 and $9.50. In examining the 52-week price action we see that the stock hit a 52-week high of $11.95 and a 52-week low of $1.52. Over the past month, the stock has gained 84.63% in value.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Lifecore Biomedical Inc., whose market valuation is $226.77 million at the time of this writing, is expected to release its quarterly earnings report Jun 01, 2023. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.13 per share this quarter, however they have predicted annual earnings per share of -$0.74 for 2023 and -$0.03 for 2024. It means analysts are expecting annual earnings per share growth of -174.10% this year and 95.90% next year.

Analysts have forecast the company to bring in revenue of $28 million for the current quarter, with the likely lows of $27 million and highs of $29 million. The average estimate suggests sales will likely down by -47.20% this quarter compared to what was recorded in the comparable quarter last year. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2023 is $200.48 million. The company’s revenue is forecast to grow by 7.90% over what it did in 2023.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Lifecore Biomedical Inc. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest LFCR has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.

Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned LFCR a recommendation rating is 2. Out of them, 1 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Lifecore Biomedical Inc. (LFCR) as Underweight, while 0 advise Sell. Analysts have rated the stock Overweight, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.

A quick review shows that LFCR’s price is currently 77.00% off the SMA20 and 96.78% off the SMA50. The RSI metric on the 14-day chart is currently showing 84.92, and weekly volatility stands at 22.42%. When measured over the past 30 days, the indicator reaches 10.19%. Lifecore Biomedical Inc. (NASDAQ:LFCR)’s beta value is currently sitting at 1.03, while the Average True Range indicator is currently displaying 0.66. With analysts defining $2.00-$8.00 as the low and high price targets, we arrive at a consensus price target of $5.00 for the trailing 12-month period. The current price is about 75.16% off the estimated low and 0.62% off the forecast high, based on this estimate. Investors will be thrilled if LFCR’s share price rises to $5.00, which is the median consensus price. At that level, LFCR’s share price would be 37.89% above current price.

To see how Lifecore Biomedical Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: LFCR stock’s performance was 50.19% in the latest trading, and -11.15% in the past year, while Air Products and Chemicals Inc. (APD) has traded -1.27% on the day and positioned 14.27% higher than it was a year ago. Another comparable company Campbell Soup Company (CPB) saw its stock close 0.54% higher in the most recent trading session but was up 12.69% in a year. Furthermore, Huntsman Corporation (HUN) showed an increase of 1.06% on the day while its price kept declining at -26.64% over the past year. Also in last trading session, the S&P 500 Index has plunged -1.12%, while the Dow Jones Industrial also saw a negative session, down -0.69% on the day.

An evaluation of the daily trading volume of Lifecore Biomedical Inc. (NASDAQ:LFCR) indicates that the 3-month average is 908.01K. However, this figure has increased over the past 10 days to an average of 1.73 million.

Currently, records show that 29.63 million of the company’s shares remain outstanding. The insiders hold 0.20% of outstanding shares, whereas institutions hold 88.60%. The stats also highlight that short interest as of Apr 27, 2023, stood at 1.64 million shares, resulting in a short ratio of 5.35 at that time. From this, we can conclude that short interest is 5.40% of the company’s total outstanding shares. It is noteworthy that short shares in April were up slightly from the previous month’s figure, which was 1.59 million. However, since the stock’s price has seen 24.23% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.

Leave a Comment

Your email address will not be published. Required fields are marked *